Compound medicine for treating gastrointestinal tract tumors

Abstract

The invention discloses a compound medicine for treating gastrointestinal tract tumors. The medicine is prepared from the following traditional Chinese medicinal raw materials in parts by weight: 3-5 parts of radix ranunculi ternati, 4-6 parts of fructus polygoni orientalis, 3-5 parts of myrrh, 3-5 parts of rabdosia rubescens, 3-5 parts of indigo naturalis, 5-8 parts of radix sophorae tonkinensis, 2-4 parts of platycodon grandiflorum, 2-4 parts of moutan bark, 6-10 parts of astragalus membranaceus, 6-8 parts of radix pseudostellariae, 1-3 parts of lucid ganoderma, 5-8 parts of donkey-hide gelatin, 8-10 parts of cortex albiziae, 2-5 parts of selfheal, 2-4 parts of radix scutellariae, 2-4 parts of cortex phellodendri, 2-4 parts of fructus forsythiae, 2-4 parts of dandelion, 2-5 parts of pleione bulbocodioides, 3-5 parts of dahurian patrinia herb, 2-3 parts of allium macrostemon, 5-8 parts of circium japonicum, 3-5 parts of seaweed and 3-5 parts of kelp. According to the traditional Chinese medical theory of strengthening and consolidating body resistance and promoting blood circulation to remove stasis, the compound medicine has the effects of tonifying liver and kidney, tonifying qi, nourishing yin, clearing heat, removing toxicity, eliminating and diminishing swelling and treating gastrointestinal tract tumors, can be used for treating both symptoms and root causes, and has the advantages of good curative effect and quick response.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicine, in particular to a compound medicine for treating gastrointestinal tumors. Background technique [0002] Gastrointestinal tumors are benign and malignant tumors that occur in the stomach, small intestine, and large intestine. Clinical manifestations vary according to the nature and location of tumor occurrence. In general, benign tumors can be asymptomatic or have very mild symptoms. Some malignant tumors have no obvious symptoms in the early stage, which affects diagnosis, treatment and prognosis. Among gastrointestinal tumors, the incidence of tumors in the small intestine is lower than that in the esophagus, stomach, and large intestine. [0003] Manifested as severe abdominal pain, intestinal bleeding, intestinal obstruction, abdominal mass and weight loss. The symptoms of malignant tumors are more and more severe, while the symptoms of benign tumors are mild or asymp...

AI Technical Summary

Problems solved by technology

In addition to conventional chemotherapy drugs, humanized antibody drugs, molecular targeted drugs, and new targeted carrier drugs are all very expensive